Axon Enterprise, Inc (NASDAQ:AXON) Given Consensus Rating of “Moderate Buy” by Brokerages

Axon Enterprise, Inc (NASDAQ:AXON) has earned a consensus rating of “Moderate Buy” from the seventeen analysts that are currently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $710.6429.

Several research analysts have recently commented on the stock. Weiss Ratings raised shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. upped their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Piper Sandler increased their target price on shares of Axon Enterprise from $674.00 to $724.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Barclays dropped their price target on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a research note on Friday, May 8th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st.

Insider Buying and Selling

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the transaction, the insider owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Patrick W. Smith sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $10,000,000.00. Following the transaction, the chief executive officer owned 3,060,997 shares in the company, valued at $1,530,498,500. This represents a 0.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 58,989 shares of company stock valued at $30,527,983 over the last ninety days. 4.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Axon Enterprise

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Creative Financial Designs Inc. ADV purchased a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $28,000. Sound Income Strategies LLC grew its position in Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after buying an additional 44 shares during the last quarter. Camelot Portfolios LLC acquired a new position in Axon Enterprise in the 4th quarter valued at $30,000. AlphaCentric Advisors LLC acquired a new position in Axon Enterprise in the 4th quarter valued at $34,000. Finally, Lodestone Wealth Management LLC purchased a new position in Axon Enterprise during the 4th quarter worth $35,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 5.4%

Shares of NASDAQ:AXON opened at $607.20 on Wednesday. The business has a 50-day moving average price of $505.32 and a 200 day moving average price of $474.90. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $48.94 billion, a price-to-earnings ratio of 243.86, a PEG ratio of 11.75 and a beta of 1.39. Axon Enterprise has a 12-month low of $339.01 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.90 million. During the same period in the prior year, the business posted $1.47 EPS. The business’s revenue for the quarter was up 33.7% compared to the same quarter last year. Sell-side analysts expect that Axon Enterprise will post 1.63 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.